Loading...

ONCOTELIC THERAPEUTICS INC Product Launches 8-K Filing

NCTL

ONCOTELIC THERAPEUTICS INC

()

2026 8-K

Joint Development Agreement

Product Launch Announcement

Research Presentation

Financing Agreement

Stock Agreement Details

Milestone Amendment

Contract Amendment

Funding Agreement Completed

Debt Financing Agreement

Access to Research Tools

Investment Offering Details

Investor Presentation Update

Equity Offerings

Presentation Announcement

External Links:

On March 24, 2026, Oncotelic Therapeutics, Inc. announced that Sapu Nano will showcase its Deciparticle ™ nanomedicine platform at Bio-Europe Spring 2026 on March 25, 2026. This event highlights advancements in Sapu Nano's clinical pipeline, where Oncotelic holds a minority interest.

AI Assistant

ONCOTELIC THERAPEUTICS INC

2026

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.